2019
DOI: 10.1016/j.tiv.2019.01.006
|View full text |Cite
|
Sign up to set email alerts
|

Prolonged erythrocyte auto-incubation as an alternative model for oxidant generation system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 86 publications
0
7
0
Order By: Relevance
“…To accomplish this aim, pharmacological doses of Mel have been employed (µM) in line with what already reported in both in vitro and in vivo investigations [15]. In particular, the choice of µM Mel doses is supported by da Silva and co-authors [19], who recently described a beneficial effect of 100 µM Mel on erythrocytes exposed to oxidative stress, as well as by Venegas and co-authors [30] reporting about the therapeutical effect of Mel administered in rats at a µM dose.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…To accomplish this aim, pharmacological doses of Mel have been employed (µM) in line with what already reported in both in vitro and in vivo investigations [15]. In particular, the choice of µM Mel doses is supported by da Silva and co-authors [19], who recently described a beneficial effect of 100 µM Mel on erythrocytes exposed to oxidative stress, as well as by Venegas and co-authors [30] reporting about the therapeutical effect of Mel administered in rats at a µM dose.…”
Section: Discussionmentioning
confidence: 99%
“…As a second step, 100 µM Mel, pharmacological dose also used in other in vitro studies [19] has been considered. Mel doses higher than 100 µM, though not causing lipid peroxidation, have not been used as out of pharmacological range used in both in vivo and in vitro investigations [15].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Among antioxidants introduced by food or adopted in clinic therapy to counteract OS, melatonin (Mel) was considered in the present study [29,30]. Melatonin, a neuroendocrine hormone primarily produced by the pineal gland, has been shown to exert its antioxidant power on lipids and proteins [31], though its antioxidant activity depends on concentration and cell target [32,33].…”
Section: Introductionmentioning
confidence: 99%